This was a personal narrative of a young woman who found she had months to live after being diagnosed with cervical cancer, and how she enrolled in a clinical trial for immunotherapy that ultimately saved her life. Immunotherapy is considered a major scientific breakthrough and is allowing some — far from all — patients to live cancer free for years. This was the first study of its kind to target immune cells against tumors driven by the HPV virus, and it showed promise in two of nine people. Sue Scott was one of them.
